Heart Failure Heart cannot pump enough blood to meet the tissue needs of the body, commonly called congestive heart failure Complex clinical syndrome.

Slides:



Advertisements
Similar presentations
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Advertisements

Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Introductory Clinical Pharmacology Chapter 39 Antiarrhythmic Drugs
Heart Failure. Objectives Describe congestive heart failure Explain the pathophysiology of congestive heart failure Describe nursing interventions in.
Congestive heart failure
Antiarrhythmic Agents: Cardiac Stimulants and Depressants
Cardiac Arrhythmia. Cardiac Arrhythmia Definition: The pumping action of the heart is coordinated by an electrical system within the heart tissue.
Cardiac drugs Cardiac glycoside Cardiac glycosides are the most effective drugs for treatment of C.H.F. Digitoxins are plant alkaloids. They increase myocardial.
Chapter 15 Respiration and Circulation. Factors That Can Alter Tissue Perfusion Cardiovascular Disease –Arteriosclerotic heart disease, hypertension,
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 22 Heart Failure Drugs.
Chapter 17 Cardiac Stimulants and Depressants. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved
Drug Therapy Heart Failure by Pat Woodbery, MSN, ARNP.
OBJECTIVES At the end of lectures the students should Describe the different classes of drugs used for treatment of acute & chronic heart failure.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 9 Tetracyclines, Macrolides, and Lincosamides.
Drugs for Heart Failure Identify the major risk factors that accelerate the progression to heart failure. 2.Relate how the classic symptoms associated.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 21 Positive Inotropic Drugs.
Nursing and heart failure
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 17 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Heart Failure Heart is unable to pump sufficient blood to meet the needs of the body. It is key symptoms are dyspnea, fatigue, fluid retention. HF is.
Kamlya balgoon 2009 AV Blocks  AV block occur when the conduction of impulse through AV node decrease or stop  Prolonged P-R interval or more P waves.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 8 Cephalosporins.
Drugs Used for Diuresis Chapter 29 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
- Calcium channel blockers decrease blood pressure,cardiac workload, and myocardial oxygen consumption. - available in immediate-release and sustained-release.
Drugs used for Congestive Heart Failure
Internal Medicine Workshop Series Laos September /October 2009
Heart Failure What is Heart Failure? The heart is not pumping properly.  Usually, the heart has been weakened by an underlying condition  Blocked arteries.
Cardiac Stimulants and Depressants
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 11 Miscellaneous Anti-Infectives.
CARDIOVASCULAR MODULE: CARDIAC FAILURE Adult Medical-Surgical Nursing.
Heart Failure  Dfinition:  Clinical features  Underlying causes of HF include Arteriosclerotic heart disease, MI, hypertensive heart disease, valvular.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 07- Penicillins.
Pharmacology Cardiovascular drugs Part I
FLUIDS AND ELECTROLYTES
Drugs Used to Treat Heart Failure
Drugs used for Congestive Heart Failure
Drug acting on the Heart
Antidysrhythmic Agents
Heart Failure The inability of the heart to pump sufficient blood to meet the needs of the tissues for oxygen and nutrients. A syndrome characterized.
Treatment of Congestive Heart Failure
Drug Therapy Heart Failure
Congestive heart failure
Hormone Secretion The thyroid gland secretes the hormones thyroxine (T4) and tri-iodothyronine (T3), which help to control metabolism. This process is.
Cardiac Cath NUR 422.
Figure 19.1 Alzheimer disease and the resulting dementia occur when changes in the brain hamper neurotransmission.
Introduction to Clinical Pharmacology Chapter 20 Antianxiety Drugs
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
Polmunary edema.
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
CNS Stimulants: Action #1
Alpha-Adrenergic Blocking Drugs: Actions and Uses
Introduction to Clinical Pharmacology Chapter 13 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Introduction to Clinical Pharmacology Chapter 11 Antiviral Drugs
Introduction to Clinical Pharmacology Chapter 42 Antidiabetic Drugs
Introduction to Clinical Pharmacology Chapter 13 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Major Hormone Secreting Glands of the Endocrine System
Dr Satti Abdelrahim Satti Pediatric Consultant
Introduction to Clinical Pharmacology Chapter 33 Diuretics
Introduction to Clinical Pharmacology Chapter 48 Urinary Tract Anti-Infectives and Other Urinary Drugs.
Cholinesterase Inhibitors: Actions and Uses
Introduction to Clinical Pharmacology Chapter 39 Antiarrhythmic Drugs
Introduction to Clinical Pharmacology Chapter 4 The Nursing Process
Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs
Introduction to Clinical Pharmacology Chapter 11 Antiviral Drugs
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
Cholinesterase Inhibitors: Actions and Uses
CNS Stimulants: Action #1
Introduction to Sedatives and Hypnotics #1
Cholinergic Blocking Drugs: Actions
Introduction to Clinical Pharmacology Chapter 26 Cholinergic Drugs
Presentation transcript:

Introduction to Clinical Pharmacology Chapter 38 Cardiotonic and Inotropic Drugs

Heart Failure Heart cannot pump enough blood to meet the tissue needs of the body, commonly called congestive heart failure Complex clinical syndrome that can result from any number of cardiac or metabolic disorders, such as ischemic heart disease, hypertension, or hyperthyroidism. Any condition that impairs the ability of the ventricle to pump blood can lead to heart failure

Ventricular Failure Left ventricular dysfunction: Condition in which fluids back up previous to the left ventricle of the heart and is characterized by shortness of breath and moist cough in HF Right ventricular dysfunction: Condition in which fluid backs up previous to the right ventricle of the heart and is characterized by peripheral edema and venous congestion in heart failure

RAA System Activation of the renin-angiotensin-aldosterone (RAA) system occurs because of decreased perfusion to the kidneys. As the RAA system is activated, angiotensin II and aldosterone levels increase, which increases the blood pressure, adding to the workload of the heart

Neurohormonal Activity Neurohormonal activity: In heart failure, increased secretions of epinephrine and norepinephrine, resulting in arteriolar vasoconstriction, tachycardia, and myocardial contractility, resulting in a worsening of heart failure and reduced ability of the heart to contract effectively

Cardiotonics: Actions and Uses Digoxin (Lanoxin) is the most commonly used cardiotonic drug. Other terms used to identify the cardiotonics are cardiac glycosides or digitalis glycosides. Actions: Increase cardiac output through positive inotropic activity; slow the conduction velocity through the atrioventricular (AV) node in the heart and decrease the heart rate through a negative chronotropic effect Uses: Used to treat heart failure; atrial fibrillation

Cardiotonics: Adverse Reactions Central nervous system reactions: Headache; weakness; drowsiness; visual disturbance Cardiovascular and gastrointestinal reactions: Arrhythmias; gastrointestinal upset; anorexia

Cardiotonics: Contraindications and Precautions Contraindicated in the presence of digitalis toxicity and in patients with known hypersensitivity, ventricular failure, ventricular tachycardia, or AV block Precautions: Patients with electrolyte imbalance, severe carditis, heart block, myocardial infarction, severe pulmonary disease, acute glomerulonephritis, impaired renal or hepatic function Digoxin and digoxin immune Fab are used cautiously during pregnancy and lactation, when the potential benefit outweighs the potential harm to the fetus

Cardiotonics: Interactions Interactant drug Effect of interaction Amiodarone Increased plasma digitalis levels, leading to toxicity Benzodiazepines Indomethacin Itraconazole Macrolides Propafenone Quinidine Spironolactone Tetracyclines Verapamil

Cardiotonics: Interactions (cont.) Interactant drug Effect of interaction Oral aminoglycoside Decreased plasma digitalis levels Antineoplastics Activated charcoal Cholestyramine Colestipol Neomycin Rifampin St. John’s wort

Cardiotonics: Interactions (cont.) The following interactions may occur with the cardiac glycosides: Interactant drug Effects of interaction Thyroid hormones Decreased effectiveness of digitalis glycosides, requiring a larger dosage of digoxin Thiazide and loop diuretics Increased diuretic-induced electrolyte disturbances, predisposing the patient to digitalis-induced arrhythmias

Miscellaneous Inotropic Drugs Inamrinone and milrinone: Have inotropic actions and are used in the short-term management of severe HF that is not controlled by the digitalis preparations Nurse must continuously monitor the patient’s heart rate and blood pressure with administration of either drug If hypotension occurs, the drug is discontinued or the rate of administration is reduced Continuous cardiac monitoring is necessary because life-threatening arrhythmias may occur

Nursing Process: Assessment Preadministration assessment: The physical assessment should include: Taking blood pressure, apical-radial pulse rate, respiratory rate Auscultating the lungs, noting any unusual sounds during inspiration and expiration Examining the extremities for edema Checking the jugular veins for distention Measuring weight

Nursing Process: Assessment (cont.) Preadministration assessment: (cont) Inspecting sputum raised (if any) and noting the appearance (e.g., frothy, pink-tinged, clear, yellow) Looking for evidence of other problems, such as cyanosis, shortness of breath on exertion (if the patient is allowed out of bed) or when lying flat, and mental changes The primary health care provider also may order laboratory and diagnostic tests

Nursing Process: Assessment (cont.) Preadministration assessment (cont.): Because digoxin reacts with many medications, the nurse must take a careful drug history Before administering the first dose of the drug, the nurse takes the patient’s vital signs and documents the apical pulse rate and rhythm

Nursing Process: Assessment (cont.) Ongoing assessment: Before administering each dose of a cardiotonic, the nurse takes the apical pulse rate for 60 seconds and records it in the designated area on the chart or the medication administration record Pulse rate below 60 bpm and above 100 bpm in adults: Withhold the drug and inform the primary health care provider

Nursing Process: Assessment (cont.) Ongoing assessment (cont.): Weigh patients receiving a cardiotonic drug daily or as ordered Assess the patient for peripheral edema and auscultate the lungs for rales or crackles throughout therapy

Nursing Process: Diagnoses Imbalanced Nutrition: Less Than Body Requirements related to anorexia, nausea, vomiting Activity Intolerance related to weakness and drowsiness

Nursing Process: Planning The expected outcomes of the patient depend on the specific reason for administering the drug but may include: Optimal response to therapy Support of patient needs related to the management of adverse reactions Understanding of and compliance with the prescribed drug regimen

Nursing Process: Implementation Promoting an optimal response to therapy The nurse should carefully check the primary health care provider’s order and the drug container Digitalization May be accomplished by two general methods: Rapid digitalization and gradual digitalization Involves giving a series of doses until the drug begins to exert a full therapeutic effect

Nursing Process: Implementation (cont.) Promoting an optimal response to therapy (cont.) Digitalization (cont.) During digitalization, the nurse takes the blood pressure, pulse, and respiratory rate every 2 to 4 hours or as ordered by the primary health care provider Periodic electrocardiograms, serum electrolytes, hepatic and renal function tests, and other laboratory studies also may be ordered

Nursing Process: Implementation (cont.) Promoting an optimal response to therapy (cont.) Parenteral administration: The nurse may give a cardiotonic orally, IV, or intramuscularly (IM) When a cardiotonic drug is given IV, it is administered slowly and the administration site is assessed for redness or infiltration When giving a cardiotonic drug IM, the nurse should rotate the injection sites

Nursing Process: Implementation (cont.) Promoting an optimal response to therapy (cont.) Oral administration: Nurse can administer oral preparations without regard to meals Monitoring and managing patient needs Risk of imbalanced nutrition: Less than body requirements: Observation of the patient for adverse reactions, such as anorexia, vomiting, nausea

Nursing Process: Implementation (cont.) Monitoring and managing patient needs (cont.) Risk of imbalanced nutrition: Less than body requirements (cont.) Carefully consider patient complaint or comment, record it on the patient’s chart, and bring to the attention of primary health care provider; offer frequent small meals instead of three large meals Activity tolerance: Patient may experience weakness and drowsiness as adverse reactions to digoxin; nurse plans a gradual increase in activities as tolerance increases; nurse assists with activities and ambulation as necessary

Nursing Process: Implementation (cont.) Monitoring and managing patient needs (cont.) Potential complication: Digitalis toxicity Observe for signs of digitalis toxicity: Every 2 to 4 hours during digitalization and one to two times a day Digoxin toxicity can be successfully treated by simply withdrawing the drug; severe life-threatening toxicity is treated with digoxin immune Fab Nurse should be alert for the possibility of worsening HF, low cardiac output, hypokalemia, or atrial fibrillation

Nursing Process: Implementation (cont.) Educating the patient and family: The patient and family must understand that the prescribed drug must be taken exactly as directed by the primary health care provider Show the patient or a family member the correct technique for taking the pulse

Nursing Process: Evaluation The therapeutic effect is achieved The patient maintains an adequate nutritional status The patient is able to carry out activities of daily living Adverse reactions are identified, reported to the primary health care provider, and managed using appropriate nursing interventions The patient verbalizes the importance of continued follow-up care

Nursing Process: Evaluation (cont.) The patient verbalizes the importance of complying with the prescribed therapeutic regimen The patient and family demonstrate an understanding of the drug regimen The patient complies with the prescribed drug regimen

Question Is the following statement true or false? Heart failure, also called congestive heart failure, is a condition in which the heart cannot pump enough blood to meet the tissue needs of the body.

Answer True Heart failure, also called congestive heart failure, is a condition in which the heart cannot pump enough blood to meet the tissue needs of the body.

Question Is the following statement true or false? Right-sided failure (right ventricular dysfunction) leads to pulmonary symptoms such as dyspnea and moist cough.

Answer False Left-sided failure (left ventricular dysfunction) leads to pulmonary symptoms such as dyspnea and moist cough. Right-sided failure (right ventricular dysfunction) can be seen with fluid backup in the body such as distended neck veins, peripheral edema, and hepatic engorgement.

Question Is the following statement true or false? Cardiotonics increase the efficiency and improve the contraction of the heart muscle.

Answer True Cardiotonics increase the efficiency and improve the contraction of the heart muscle.

Question When a cardiotonic is used the pulse rate is monitored. For which of the following heart rates would the medication be held? A. 60 beats per minute B. 70 beats per minute C. 80 beats per minute D. 90 beats per minute

Answer A Rationale: When a cardiotonic is used the pulse rate is monitored and the drug is held if the patient’s heart rate is less than 60 beats per minute. Adverse reactions are typically GI in nature, and patients need to be monitored for toxicity to the drug, which can appear as GI distress, changes in vision, or muscle weakness.